Advancing vaginal drug delivery

Expert Opinion on Drug Delivery

Volumn 2, Issue 4, 2005, Pages 769-777

  Merabet, Jennifer ^a   Thompson, Daniel ^a   Levinson, R Saul ^a  

^a KV Pharmaceutical Company   (United States)

Author keywords

Bacterial vaginosis; Bioadhesion; Butoconazole; Clindamycin; Sustained release; Vaginal drug delivery; Vaginitis; Vulvovaginal candidiasis

Indexed keywords

ANTICOAGULANT AGENT; ANTIFUNGAL AGENT; BUTOCONAZOLE; CARBAMAZEPINE; CIMETIDINE; CLINDAMYCIN; CLINDAMYCIN PHOSPHATE; CLOTRIMAZOLE; CYCLOSPORIN; CYTOCHROME P450; FLUCONAZOLE; GYNAZOLE 1; METRONIDAZOLE; MICONAZOLE; ORAL ANTIDIABETIC AGENT; PHENOBARBITAL; PHENYTOIN; TACROLIMUS; UNCLASSIFIED DRUG; WARFARIN;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; BLEEDING; BURNING SENSATION; CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; DRUG ABSORPTION; DRUG ADMINISTRATION ROUTE; DRUG ALCOHOL INTERACTION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDICATION; DRUG METABOLISM; DRUG RELEASE; DRUG SAFETY; DRUG UTILIZATION; FEMALE; FEMALE INFERTILITY; HEADACHE; HUMAN; INFECTION CONTROL; MULTICENTER STUDY; MYCOSIS; NAUSEA; PATIENT COMPLIANCE; PELVIC INFLAMMATORY DISEASE; PELVIS PAIN SYNDROME; PERIPHERAL NEUROPATHY; PREGNANCY COMPLICATION; PREMATURE LABOR; PSEUDOMEMBRANOUS COLITIS; SEIZURE; SEXUALLY TRANSMITTED DISEASE; SINGLE DRUG DOSE; TREATMENT OUTCOME; VAGINA CANDIDIASIS; VAGINAL PRURITUS; VAGINITIS;

ADMINISTRATION, INTRAVAGINAL; CANDIDIASIS, VULVOVAGINAL; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; VAGINA; VAGINOSIS, BACTERIAL;

EID: 22844437125     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.2.4.769     Document Type: Article

References (24)

1. SCHWEBKE JR: Gynecologic consequences of bacterial vaginosis. Obstet. Gynecol. Clin. N. Am. (2003) 30(4):685-694.
2. SOBEL JD: Vaginitis. N. Engl. J. Med. (1997) 337(26):1896-1902.
3. MIKAMO H, KAWAOE K, IZUMI K, WATANABE K, UENO K, TAMAYA T: Comparative study on vaginal or oral treatment of bacterial vaginosis. Chemotherapy (1997) 43(1):60-68.
4. WEINSTEIN L, HENZEL MR, TSINA IW: Vaginal retention of 2% butoconazole nitrate cream: comparison of a standard and a sustained-release preparation. Clin. Ther. (1994) 16(6):930-934.
5. THOMPSON DJ, LEVINSON RS: A bioadhesive topical drug delivery system. Drug Delivery Systems & Sciences (2002) 2(1):17-19.
6. Data on File, KV Pharmaceutical.
7. BROWN D, HENZL MR, KAUFMAN RH: Butoconazole nitrate 2% for vulvovaginal candidiasis. New, single-dose vaginal cream formulation vs. seven-day treatment with miconazole nitrate. Gynazole 1 Study Group. J. Repr. Med. (1999) 44(11):933-938.
8. Data on File, KV Pharmaceutical.
9. Gynazole-1® Package Insert. Ther-Rx Corporation.
10. Diflucan® Package Insert. Pfizer Pharmaceuticals.
11. Data on File, KV Pharmaceutical.
12. SCHLICHT JR: Treatment of bacterial vaginosis. Ann. Pharmacother. (1994) 28(4):483-487.
13. AMSEL R, TOTTEN PA, SPIEGEL CA, CHEN KC, ESCHENBACH D, HOLMES KK: Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. (1983) 74(1):14-22.
14. CAREY JC, KLEBANOFF MA: Bacterial vaginosis and other asymptomatic vaginal infections in pregnancy. Curr. Womens Health Rep. (2001) 1(1):14-19.
15. PAAVONEN J, MANGIONI C, MARTIN MA, WAJSZCZUK CP: Vaginal clindamycin and oral metronidazole for bacterial vaginosis: a randomized trial. Obstet. Gynecol. (2000) 96(2):256-260.
16. FERRIS DG, LITAKER MS, WOODWARD L, MATHIS D, HENDRICH J: Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream. J. Fam. Pract. (1995) 41(5):443-449.
17. ANDRES FJ, PARKER R, HOSEIN I, BENRUBI GI: Clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis: a prospective double-blind clinical trial. South. Med. J. (1992) 85(11):1077-1080.
18. Metro-Gel® Package Insert. 3M Pharmaceuticals.
19. Cleocin® Vaginal Cream. Pfizer Pharmaceuticals.
20. CUNNINGHAM FE, KRAUS DM, BRUBAKER L, FISCHER JH: Pharmacokinetics of intravaginal metronidazole gel. J. Clin. Pharmacol. (1994) 34(11):1060-1065.
21. Data on File, KV Pharmaceutical
22. Cleocin Vaginal Ovules. Pfizer Pharmaceuticals.
23. Clindesse. Ther-Rx Corporation/KV Pharmaceuticals.
24. RICHTER A, ANTON SE, KOCH P, DENNETT SL: The impact of reducing dose frequency on health outcomes. Clin. Ther. (2003) 25(8):2307-2335.